Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
head and neck cancer
Biotech
Calliditas' cancer trial misses primary goal, hits on survival
Calliditas saw no change in tumor size but bounced back up with early evidence of an effect on progression-free and overall survival.
Nick Paul Taylor
May 7, 2024 6:39am
Ultimovacs lays off 40% in wake of cancer vaccine's phase 2 fail
Apr 17, 2024 8:22am
Bicara raises second $100M+ round of 2023, closing new series C
Dec 12, 2023 6:30am
Merus shares dip as lung cancer data reveal 3 patient deaths
Dec 4, 2023 1:04pm
Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3
Sep 29, 2023 10:00am
FDA request extends CEL-SCI's multidecade Multikine journey
Jul 14, 2023 10:32am